RESEARCH ARTICLE: Assessment of knowledge and awareness regarding opioid overdose and toxicity among a sample of healthcare providers
DOI:
https://doi.org/10.46542/pe.2022.221.265275Keywords:
Knowledge, Naloxone, Opioids training programme, Opioids overdose, Prescribers’ awarenessAbstract
Background: Knowledge and attitudes of healthcare providers regarding opioid toxicity are significant concerns.
Objective: Investigate the knowledge, attitudes, awareness, and comfort level regarding overdosing among a sample of healthcare providers working at the Armed Forces Hospital Southern Region (AFHSR).
Methods: Anonymous surveys were administered to AFHSR staff to assess attitude, knowledge, comfort level, and fear of consequences using a 5-point scale. Participants were AFHSR primary care physicians/internists, surgeons, physician assistants/advanced practice registered nurses, and pharmacists.
Results: Healthcare providers demonstrated a lack of knowledge, awareness, and fear of the consequences associated with opioid use, overdose, and the indications and administration of naloxone. This study’s findings indicate that healthcare providers are hesitant to engage in discussions with patients about preventative measures for opioid overdose, with the majority believing that doing so will make no difference in preventing opioid overdose incidence. Additionally, a distinct difference in knowledge and perceptions of opioid abuse and toxicity was found between nurses and physicians. Further, the findings indicate a difference in knowledge and awareness regarding opioid overdose and toxicity between nurses and pharmacists.
References
Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010). Preventing opiate overdose deaths: examining objections to take-home naloxone. Journal of health care for the poor and underserved, 21(4), 1108
Behar, E., Bagnulo, R., & Coffin, P. O. (2018). Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive medicine, 114, 79-87. https://doi.org/10.1016/j.ypmed.2018.06.005
Binswanger, I. A., Koester, S., Mueller, S. R., Gardner, E. M., Goddard, K., & Glanz, J. M. (2015). Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. Journal of general internal medicine, 30(12), 1837-1844. https://doi.org/10.1007/s11606-015-3394-3
Bohnert, A. S., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315-1321. https://doi.org/10.1001/jama.2011.370
Bounthavong, M., Suh, K., Christopher, M. L., Veenstra, D. L., Basu, A., & Devine, E. B. (2020). Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment. Research in Social and Administrative Pharmacy, 16(8), 1033-1040. https://doi.org/10.1016/j.sapharm.2019.10.015
Coe, M. A., & Walsh, S. L. (2015). Distribution of naloxone for overdose prevention to chronic pain patients. Preventive medicine, 80, 41-43. https://doi.org/10.1016/j.ypmed.2015.05.016
Coffin, P. O., Behar, E., Rowe, C., Santos, G. M., Coffa, D., Bald, M., & Vittinghoff, E. (2016). Nonrandomized intervention study of naloxone co-prescription for primary care patients receiving long-term opioid therapy for pain. Annals of internal medicine, 165(4), 245-252. https://doi.org/10.7326/M15-2771
Darke, S., & Hall, W. (1997). The distribution of naloxone to heroin users. Addiction, 92(9), 1195-1200. https://doi.org/10.1111/j.1360-0443.1997.tb03681.x
Devries, J., Rafie, S., & Polston, G. (2017). Implementing an overdose education and naloxone distribution program in a health system. Journal of the American Pharmacists Association, 57(2), S154-S160. https://doi.org/10.1016/j.japh.2017.01.002
Dixit, D., Endicott, J., Burry, L., Ramos, L., Yeung, S. Y. A., Devabhakthuni, S., ... & Bulloch, M. N. (2016). Management of acute alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(7), 797-822. https://doi.org/10.1002/phar.1770
Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—the United States, 2016. JAMA, 315(15), 1624-1645. https://doi.org/10.1001/jama.2016.1464
Doyon, S., Aks, S. E., & Schaeffer, S. (2014). Expanding access to naloxone in the United States. Clinical Toxicology, 52(10), 989-992. https://doi.org/10.3109/15563650.2014.968657
Dwyer, K. H., Samuels, L., Moore, R. L., Langlois, B. K., Mitchell, P. M., Grimsman, J., & Bernstein, E. (2013). Physician attitudes and perceived barriers to prescribing nasal naloxone rescue kits in the emergency department. Annals of Emergency Medicine, 62(4), S43. https://doi.org/10.1016/j.annemergmed.2013.07.400
Foldes, F. F. (1964). The human pharmacology and clinical use of narcotic antagonists. Medical Clinics of North America, 48(2), 421-443. https://doi.org/10.1016/S0025-7125(16)33474-5
Gatewood, A. K., Van Wert, M. J., Andrada, A. P., & Surkan, P. J. (2016). Academic physicians' and medical students' perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addictive behaviors, 61, 40-46. https://doi.org/10.1016/j.addbeh.2016.05.013
Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Injury epidemiology, 2(1), 1-9. https://doi.org/10.1186/s40621-015-0041-8
Glanz, J. M., Narwaney, K. J., Mueller, S. R., Gardner, E. M., Calcaterra, S. L., Xu, S., ... & Binswanger, I. A. (2018). Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy. Journal of general internal medicine, 33(10), 1646-1653. https://doi.org/10.1007/s11606-017-4288-3
Green, T. C., Bowman, S. E., Zaller, N. D., Ray, M., Case, P., & Heimer, R. (2013). Barriers to medical provider support prescription naloxone as overdose antidote for lay responders. Substance use & misuse, 48(7), 558-567. https://doi.org/10.3109/10826084.2013.787099
Haffajee, R. L., & French, C. A. (2019). Provider perceptions of system-level opioid prescribing and addiction treatment policies. Current opinion in psychology, 30, 65-73. https://doi.org/10.1016/j.copsyc.2019.01.018
Haug, N. A., Bielenberg, J., Linder, S. H., & Lembke, A. (2016). Assessment of provider attitudes toward# naloxone on Twitter. Substance abuse, 37(1), 35-41. https://doi.org/10.1080/08897077.2015.1129390
Hsu, D. J., McCarthy, E. P., Stevens, J. P., & Mukamal, K. J. (2017). Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001–12. Addiction, 112(9), 1558-1564. https://doi.org/10.1111/add.13795
Kunins, H. V., Sohler, N. L., Giovanniello, A., Thompson, D., & Cunningham, C. O. (2013). A buprenorphine education and training program for primary care residents: implementation and evaluation. Substance abuse, 34(3), 242-247. https://doi.org/10.1080/08897077.2012.752777
Mattson, C. L., Schieber, L., Scholl, L., Rudd, R. A., Seth, P., Xu, L., ... & Paulozzi, L. J. (2017). Annual surveillance report of drug-related risks and outcomes—the United States, 2017
McDonald, R., & Strang, J. (2016). Are take‐home naloxone programmes effective? Systematic review utilizing the application of the Bradford Hill criteria. Addiction, 111(7), 1177-1187. https://doi.org/10.1111/add.13326
Monteiro, K., Dumenco, L., Collins, S., Bratberg, J., MacDonnell, C., Jacobson, A., ... & George, P. (2017). An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills. Journal of the American Pharmacists Association, 57(2), S113-S117
Mueller, S. R., Koester, S., Glanz, J. M., Gardner, E. M., & Binswanger, I. A. (2017). Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. Journal of general internal medicine, 32(3), 277-283. https://doi.org/10.1016/j.japh.2016.12.069
Peckham, A. M., Niculete, M. E., Steinberg, H., & Boggs, D. L. (2018). A survey of prescribers' attitudes, knowledge, comfort, and fear of consequences related to opioid overdose education and naloxone distribution program. Journal of public health management and practice, 24(4), 310-317. https://doi.org/10.1097/PHH.0000000000000668
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths—the United States, 2000–2014. Morbidity and mortality weekly report, 64(50-51), 1378-1382. https://doi.org/10.15585/mmwr.mm6450a3
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths—the United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(51-52), 1419. https://doi.org/10.15585/mmwr.mm675152e1
Sporer, K. A. (2003). Strategies for preventing heroin overdose. BMJ, 326(7386), 442-444. https://doi.org/10.1136/bmj.326.7386.442
Strang, J., McDonald, R., Campbell, G., Degenhardt, L., Nielsen, S., Ritter, A., & Dale, O. (2019). Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine. Drugs, 79(13), 1395-1418. https://doi.org/10.1007/s40265-019-01154-5
Thakur, T., Frey, M., & Chewning, B. (2020). Pharmacist roles, training, and perceived barriers in naloxone dispensing: a systematic review. Journal of the American Pharmacists Association, 60(1), 178-194. https://doi.org/10.1016/j.japh.2019.06.016
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., ... & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ, 346. https://doi.org/10.1136/bmj.f174
Wermeling, D. P. (2013). A response to the opioid overdose epidemic: naloxone nasal spray. Drug delivery and translational research, 3(1), 63-74. https://doi.org/10.1007/s13346-012-0092-0
Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J. (2015). Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR. Morbidity and mortality weekly report, 64(23), 631
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., ... & Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The lancet, 382(9904), 1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6
Winstanley, E. L., Clark, A., Feinberg, J., & Wilder, C. M. (2016). Barriers to implementation of opioid overdose prevention programs in Ohio. Substance abuse, 37(1), 42-46. https://doi.org/10.1080/08897077.2015.1132294
Yarlagadda, K., Kim, J., Kanderi, T., Sendil, S., & Nookala, V. K. (2020). Opioid antidote induced pulmonary edema and lung injury. Respiratory medicine case reports, 30, 101107. https://doi.org/10.1016/j.rmcr.2020.101107
